{
    "nctId": "NCT03847168",
    "briefTitle": "KN026 in Patients With HER2 Expressing Breast Cancer and Gastric Cancer",
    "officialTitle": "Phase I Study of KN026 in HER2 Expressing Breast Cancer, Astric/Gastroesophageal Junction Cancer and Other Locally Advanced/Metastatic Solid Tumors",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer, Gastric/Gastroesophageal Junction Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 22,
    "primaryOutcomeMeasure": "The proportion of patients experiencing dose limiting toxicities",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or female subject \\>= 18 years\n* Histologically/cytologically confirmed, locally advanced unresectable or metastatic breast cancer or gastric cancer.\n* ECOG score 0 or 1\n* Life expectancy \\>3 months\n* According to the definition of RECIST1.1, the patient has at least one measurable lesion\n* Adequate organ function prior to start treatment with KN026\n* Able to understand, voluntarily participate and willing to sign the ICF\n* Subjects (women of child-bearing potential and males with fertile female partner) must be willing to use viable contraception method.\n\nExclusion Criteria:\n\n* Accepted any other anti-tumor drug therapies within 4 weeks before fist dose\n* Accepted radiotherapy within 4 weeks before enrollment\n* An anthracyclines antibiotic treatment was received exceeding 300 mg/m\u00b2 within 90 days before first KN026 dosing, or other equivalent dose antharcyclines\n* Subjects are eligible with clinically controlled and stable neurologic function \\>= 4 weeks, which is no evidence of CNS disease progression; Subjects with spinal cord compression and cancerous meningitis are not eligible\n* Pregnant or nursing females\uff1bor intend pregnancy within this study period or within 6 monthes after the end of this study\n* History of immunodeficiency, including HIV positive or other acquired, congenital immunodeficiency disease, or a history of organ transplantation\n* Severe chronic and active infection, need to system antibiosis/antiviral treatment\n* Cavity effusion (pleural effusion, ascites, pericardial effusion, etc.) are not well controlled, and need locally treatment or repeated drainage",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}